Ara
Toplam kayıt 1, listelenen: 1-1
Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study
(2020)
Objective
To evaluate prognostic factors associated with the use of ipilimumab in patients with mucosal and uveal melanoma.
Methods
In this multicenter, retrospective study, 31 patients with uveal and mucosal ...